Developer of a blood-based cancer diagnostics platform designed to improve clarity in disease detection. The company offers the IsoPSA test for prostate cancer, built on its IsoClear platform that mea...

Healthcare
Cleveland, OH, United States
Founded 2013
89 employees
Website
Valuation
$285.2M
Market implied
Share Price
N/A
Total Raised
$126.1M
Last Round
N/A

Get the full picture

Create a free account to unlock ClevelandDx's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required